hTERT multipeptide vaccine (King’s College London/University of Nottingham/University of Hull)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamehTERT multipeptide vaccine (King’s College London/University of Nottingham/University of Hull)
Drug Alias NamehTERT vaccine (Kings College London/Univ Nottingham/Univ Hull)
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKing'S College London
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A